- Home
- / Daewoong Pharmaceutical
Daewoong Pharmaceutical
Stock Price
₩123.3 K
2024-08-14
Market Capitalization
₩1.4 T
2024-08-14
Revenue
₩1.8 T
FY, 2023
Daewoong Pharmaceutical Summary
Company Summary
- Overview
- Daewoong Pharmaceutical is a healthcare company that provides pharmaceutical solutions and services. It offers products in therapeutic areas, such as endocrinology, central nervous system, musculoskeletal, nephrology, antineoplastic, cardiovascular, and other diseases.
- Type
- Public
- Status
- Active
- Founded
- 1945
- HQ
- Seoul, KR | view all locations
- Website
- https://www.daewoong.co.kr
- Cybersecurity rating
Table of Contents
LocationsView all
11 locations detected
Seoul, Seoul HQ
Korea (Republic of)
12 Bongeunsa-ro 114-gil
Cambridge, MA
United States
1 Broadway
Beijing, Bei Jing Shi
China
Room 30505, Unit C, Galaxy SOHO, A7, Xiaopaifang Street
Benxi, Liao Ning Sheng
China
NO. No. 5, Chun-an street
Hyderabad, TG
India
Plot No. 5A, APIIC, IE, Prashanth Nagar, Kukatpally
Jakarta, Daerah Khusus Ibukota Jakarta
Indonesia
27th UOB Plaza Unit 5, MH Thamrin No. 10
Daewoong Pharmaceutical Financials
Summary Financials
- Revenue (FY, 2023)
- ₩1.8T
- Gross profit (FY, 2023)
- ₩981.0B
- Net income (FY, 2023)
- ₩191.4B
- Cash (FY, 2023)
- ₩161.7B
- EBIT (FY, 2023)
- ₩205.1B
- Enterprise value
- $1.7T
News
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2024